IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price Rule
TORONTO and GLIL YAM, Israel, Jan. 31, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company,” “IMCannabis,” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, announced today that it has received a 180 calendar day extension, until July 29, 2024, from the Nasdaq Stock Market (“Nasdaq“), to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) (the “Bid Price Rule“).
Related news for (IMCC)
- IM Cannabis Announces Board Changes and Strategic Decision to Identify Additional Business Opportunities
- IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement
- IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing
- IM Cannabis Reports Second Quarter 2025 Financial Results
- IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million